Image

Global Bone Marrow-Derived Stem Cells (BMSCS) Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
  • Healthcare
  • Upcoming Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Bone Marrow-Derived Stem Cells (BMSCS) Market, By Service Type (Sample Preservation and Storage, Sample Analysis, Sample Processing, Sample Collection and Transportation), Application (Personalized Banking Applications, Research Applications, Clinical Applications) – Industry Trends and Forecast to 2029.

Bone Marrow-Derived Stem Cells (BMSCS) Market

Global Bone Marrow-Derived Stem Cells (BMSCS) Market Analysis and Size

Bone marrow biopsy is increasingly gaining attraction apart from the western economies. Rising incorporation of advanced healthcare technologies in the developing economies all around the world is carving the way for the growth of the market. Owing to the ease of harvesting and multilinear differentiation potential, bone marrow-derived stem cells (BMSCS) market has a bright future.

  • Data Bridge Market Research analyses that the bone marrow-derived stem cells (BMSCS) market is expected to undergo a CAGR of 10.90% during the forecast period. This indicates that the market value, which was USD 7.45 billion in 2021, would rocket up to USD 17.04 billion by 2029. “Sample Preservation and Storage” dominates the service type segment of the bone marrow-derived stem cells (BMSCS) market owing to the rising awareness about the practice of preserving blood cell from a new-born baby for future use.

Global Bone Marrow-Derived Stem Cells (BMSCS) Market Definition

Bone marrow-derived stem cells (BMSCS) are the multipotent adult stem cells with multilineage differentiation potential. Bone marrow-derived stem cells (BMSCS) help in repairing the broken or damaged bone through secretion of factors that stimulate endogenous repair processes.            

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Service Type (Sample Preservation and Storage, Sample Analysis, Sample Processing, Sample Collection and Transportation), Application (Personalized Banking Applications, Research Applications, Clinical Applications)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Cord Blood Registry Systems (US), Cordlife Group Limited (Singapore), Cryo-Cell International (US), ViaCord (US), Cryo-Save AG (Netherlands), LifeCell International (India), StemCyte (US), Global Cord Blood Corporation (China), Smart Cells International (UK), Vita34 AG (Germany), Abbott (US), BD (US), Takara Bio Inc. (Japan) and CryoHoldco (Mexico)    

Market Opportunities

  • Growth in the awareness about the benefits of stem cell banking
  • Increasing number of bone marrow disorders
  • Rising research and development opportunities

Bone Marrow-Derived Stem Cells (BMSCS) Market Dynamics

Drivers

  • Rising prevalence of diseases

Growing prevalence of problems accompanies with the bone marrow diseases all around the globe is one of the major factors responsible for the growth of the market. In other words, rising incidence rate of leukaemia, aplastic anaemia, myeloproliferative disorders, and others is inducing growth of the market.

  • Research and development proficiencies

Rising expenditure for research and development proficiencies especially in the developed and developing economies will further create lucrative market growth opportunities. Research and development proficiencies being conducted for sample analysis and transportation is also bolstering the market growth rate.

  • Growing development of healthcare infrastructure  

Surging number of public private partnerships for the development of healthcare facilities and infrastructure especially in the developing economies is fostering the growth of the market. Rising introduction of novel technologies for the preservation of stem cells and their storage as a collaborative effort of public and private players is further bolstering the growth of the market.     

Opportunities

Furthermore, upsurge in the public-private funding for target research activities, rising awareness about the benefits of , growing awareness on the therapeutic potential of stem cells, rising development of novel technologies for stem cell preservation, processing and storage, rising geriatric population base and rising product innovations and development owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2022 to 2029. Additionally, rise in the birth rate, high operational costs associated with stem cell banking and increasing per capita expenditure on health care will further expand the market's growth rate in the future.    

Restraints/Challenges  Global Bone Marrow-Derived Stem Cells (BMSCS) Market

On the other hand, high cost associated with the research and development proficiencies, limited infrastructural facilities, uneven distribution of medical services and dearth of awareness in the backward economies are expected to obstruct market growth. Also, lack of favorable reimbursement scenario and technology penetration in the developing economies, high operational costs associated with stem cell banking, stringent regulatory framework, limited insurance coverage and regulatory compliance, and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2022-2029.

This bone marrow-derived stem cells (BMSCS) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the bone marrow-derived stem cells (BMSCS) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Bone Marrow-Derived Stem Cells (BMSCS) Market

COVID-19 had a negative impact on the market. This is because of the significant disruptions experienced by their respective manufacturing companies in the pandemic era. Also, disruptions in the supply-chain operations as a result of various precautionary lockdowns further restricted the growth in this phase. Further the aim of individuals to reduce the non-essential expenses in this pandemic phase narrowed down the scope of growth. Also, restrictions imposed on the movement further created hindrances. However, the future of the market is in good shape.

Global Bone Marrow-Derived Stem Cells (BMSCS) Market Scope

The bone marrow-derived stem cells (BMSCS) market is segmented on the basis of service type and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Service type

  • Sample Preservation and Storage
  • Sample Analysis
  • Sample Processing
  • Sample Collection
  • Transportation

Based on service type, bone marrow-derived stem cells (BMSCS) market is segmented into sample preservation and storage, sample analysis, sample processing, sample collection and transportation.

Application

  • Personalized Banking Applications
  • Research Applications
  • Clinical Applications

Bone marrow-derived stem cells (BMSCS) market has also been segmented based on the application into personalized banking applications, research applications and clinical applications. Research applications have been further segmented into disease treatment studies, life science research and drug discovery. Clinical applications have been further segmented into hematopoietic disorders, autoimmune disorders and other diseases.

Bone Marrow-Derived Stem Cells (BMSCS) Market Regional Analysis/Insights

The bone marrow-derived stem cells (BMSCS) market is analysed and market size insights and trends are provided by country, service type and application as referenced above.

The major countries operating in the bone marrow-derived stem cells (BMSCS) market are U.S., Canada, Mexico in North America, Germany, Sweden, Poland, Denmark, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe in Europe, Japan, China, India, South Korea, New Zealand, Vietnam, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), Brazil, Argentina, Rest of South America as a part of South America, UAE, Saudi Arabia, Oman, Qatar, Kuwait, South Africa, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America dominates the market because of the strong base of healthcare facilities, increasing stem cell procedure along with preferences of private stem cell banking over public and surging network of stem cell banking services and rising number of research activities in this region.  

Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, availability of massive untapped markets, large population pool, and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Bone Marrow-Derived Stem Cells (BMSCS) Market Share Analysis

The bone marrow-derived stem cells (BMSCS) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to bone marrow-derived stem cells (BMSCS) market.

Some of the major players operating in the bone marrow-derived stem cells (BMSCS) market are:

  • Cord Blood Registry Systems (US)
  • Cordlife Group Limited (Singapore)
  • Cryo-Cell International (US)
  • ViaCord (US)
  • Cryo-Save AG (Netherlands)
  • LifeCell International (India)
  • StemCyte (US)
  • Global Cord Blood Corporation (China)
  • Smart Cells International (UK)
  • Vita34 AG (Germany)
  • Abbott (US)
  • BD (US)
  • Takara Bio Inc. (Japan)
  • CryoHoldco (Mexico)    

Research Methodology : Global Bone Marrow-Derived Stem Cells (BMSCS) Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-bone-marrow-derived-stem-cells-bmscs-market


SKU-

Why Choose Us


Frequently Asked Questions

The Bone Marrow-Derived Stem Cells (BMSCS) Market is expected to value USD 17.04 billion by 2029.
The Bone Marrow-Derived Stem Cells (BMSCS) Market is Projected to Grow at a CAGR of 10.90% During the Forecast Period of 2022 to 2029.
Cord Blood Registry Systems (US), Cordlife Group Limited (Singapore), Cryo-Cell International (US), ViaCord (US), Cryo-Save AG (Netherlands), LifeCell International (India), StemCyte (US), Global Cord Blood Corporation (China), Smart Cells International (UK), Vita34 AG (Germany), Abbott (US), BD (US), Takara Bio Inc. (Japan) and CryoHoldco (Mexico) are the Major Companies Operating in Bone Marrow-Derived Stem Cells (BMSCS) Market.
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
The Bone Marrow-Derived Stem Cells (BMSCS) Market Report Curated by the Data Bridge Market Research Team Includes In-Depth Expert Analysis, Patient Epidemiology, Pipeline Analysis, Pricing Analysis, and Regulatory Framework.